The Great White guitarist, who announced his stage 4 kidney cancer diagnosis last year, revealed that his latest scans show ...

Mark Kendall, the guitarist for the legendary rock band Great White, first announced that he has been battling stage 4 kidney ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

January 07, 2026-- NeuraLight, the leader in developing precision biomarkers for neurology, today announced the completion of PALOMA, a pioneering study comparing eye-movement measures with standard ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

PALOMA study is one of the largest longitudinal studies using eye-movement biomarkers in patients with Parkinson’s diseaseNEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--NeuraLight, the leader in ...

Our thoughts are with the friends and family of Steve as well as all those who have lost a loved one on our latest list ...

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

Cytora Therapeutics Ltd. (Cytora), a clinical-stage biotechnology company based in Israel developing allogeneic, stem cell therapies; Made Scientific, Inc. (Made Scientific), a leading U.S.-based cell ...

Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...

Locals make predictions and more Predicting the future is a dicey business. A year ago, who could have imagined some of the ...

Former radio DJ Kim Johnston is suffering from symptoms like severe speech impairment, jaw instability and is dependent on a ...